Vimta Labs share news, announcements and annual reports
NSE: VIMTALABSBSE: 524394Healthcare ServicesSmall Cap
Vimta Labs Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1994 on BSE, Dec 2005 on NSE
Last close ₹484.90down ₹34.90 (6.71%)BSE ₹484.85
Share price at the NSE close on 30 Oct 2026. Previous close ₹519.80.
30 Oct: open ₹519.90, high ₹522.50, low ₹480.35
52-week range of traded prices to 30 Oct 2026
₹376.05Low, 30 Mar 2026₹735.00High, 3 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,167 Cr1,128th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.97
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.41
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.41%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,41,24221.5% delivered
Vimta Labs disputes and clarifications
17 filed, newest first.
Aug 2026
31 Aug · Legal
The exchange asked on 31 Aug 2026
Jul 2025
29 Jul · Legal
The exchange asked on 29 Jul 2025
Feb 2025
12 Feb · Legal
The exchange asked on 11 Feb 2025
Apr 2024
25 Apr · Legal
The exchange asked on 25 Apr 2024
Dec 2021
7 Dec · Legal
The exchange asked on 6 Dec 2021
Apr 2021
14 Apr · Legal
The exchange asked on 13 Apr 2021
Apr 2020
16 Apr · Legal
The exchange asked on 15 Apr 2020
Aug 2019
12 Aug · Legal
Exchange has sought clarification from Vimta Labs Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Consolidated Financial Results not submitted The response of the Company is awaited.
Jul 2019
22 Jul · Legal
Exchange has sought clarification from Vimta Labs Limited with respect to announcement dated 15-Jul-2019, regarding 'Intimation of Cessation / Appointment of term of Directors'. On basis of above the Company is required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director) 2. Brief profile of Directors appointed.The response of the Company is awaited.
May 2019
27 May · Legal
Exchange has sought clarification from Vimta Labs Limited with respect to announcement dated 11-May-2019, regarding Outcome of Board Meeting held on May 11, 2019.". On basis of above the Company is required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director)The response of the Company is awaited.
Aug 2017
17 Aug · Legal
Exchange has sought clarification from Vimta Labs Limited with respect to announcement dated 17-Aug-2017, regarding "Change in Auditors of the company.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment);The response of the Company is awaited.
Mar 2015
18 Mar · Legal
Price movement : Significant price movement has been observed in Vimta Labs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Vimta Labs Limited has vide its letter inter-alia stated, "The Company neither had any events, information, etc that has a bearing on the operation / performance nor any price sensitive information. Further, the Company doesn't have any impending announcements."